Singapore healthcare players urged to expand in China as local growth slows | Healthcare Asia Magazine
, Singapore

Singapore healthcare players urged to expand in China as local growth slows

Their strict regulations are finally easing.

According to a report by OCBC, China’s healthcare sector may be fertile ground for investment.

The Chinese government has been easing the strict regulatory process for foreign investment in the healthcare sector, and has set a goal for private hospital services to increase contribution to the overall sector.

Further, the Chinese healthcare sector is also bolstered by substantial government spending, rising consumer wealth, as well as an aging population.

As quality of care and long waiting time are significant issues for public healthcare providers, private players can easily grab growth opportunities with their strong international branding.

Already, deals within the sector–including private hospital development projects–have been rising.

In May 2015, Raffles Medical Group clinched a joint venture with Shanghai LuJiaZui Group to develop a 400-bed international general hospital in Shanghai’s Pudong Area by 2018.

Other private players, such as Ramsay Health Care and International Healthcare Berhad (IHH), have announced expansion plans in other Chinese cities as well. IHH already inked a lease arrangement to operate a 350-bed hospital scheduled to open in 2017 at the Perennial International Health and Medical Hub in Chengdu.

Outside of hotel operators, healthcare service providers like Q&M Dental are also looking to expand in China. As of November 2015, Q&M Dental had seven dental establishments in China, and had proposed a spin-off dental supplies manufacturing business on the New Third Board. 

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.